Cambridge company FSIF COVID BioScience applies for patent on innovative new COVID-19 test
CAMBRIDGE - FSIF COVID BioScience, a biotechnology company focused on harnessing the power of the human immune system to diagnosis and treat COVID-19, announced on June 15 they hav…
